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Abstract 
Damage caused by administering general anesthetics to the developing brain in young 
children and pregnant mothers is of concern among practicing anesthesia providers. 
Studies using young rodents and non-human primates have shown that animals are 
susceptible to neurodegeneration when exposed to high concentrations of general 
anesthesia. Randomized control trials using rodents as subjects used behavioral and 
histological experiments to determine the adverse effects of general anesthetics including 
the inhalation agents desflurane, isoflurane, and sevoflurane in addition to intravenous 
ketamine. The purpose of this systematic review was to examine the current literature to 
determine the effects these anesthetics pose on rodent subjects and how that translates 
into the human population. This systematic review was constructed using both PRISMA 
and ARRIVE as guidelines. A literature review was conducted and data was collected 
from each study. A cross-study analysis was created through data collected from each 
study by the author of this systematic review. The randomized control trials reviewed 
provide evidence that the types of inhalation and intravenous anesthesia agents studied 
can affect the developing brains of rodents. Anesthesia providers can use these results as 
a guide when administering anesthesia to infants, young children, and gravid mothers, 
however, more studies focusing on the long-term effects these agents have on children 
are warranted. 
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THE EFFECT OF ANESTHESIA ON THE DEVELOPING BRAIN 
Background/Statement of the Problem 
Potential damage caused by administering general anesthetics to the developing 
brain in young children and pregnant mothers is of grave concern among practicing 
anesthesia providers. Anesthetic agents and drugs could adversely affect the brain of 
children as it develops by possibly disrupting normal neuroapoptosis (Aker, Block & 
Biddle, 2015). Neuroapoptosis is the body's normal controlled cell death that is crucial in 
the role of brain development (Aker et al., 2015). Controlled cell death plays a vital role 
in neurodevelopment and helps to limit redundancy, faulty neurons, or unused neurons 
from crowding the developing brain (Creely, 2016).  
Anesthesia can disrupt this normal development by altering neuroapoptosis and 
increasing neurodegeneration, causing unwanted damage (Reddy, 2012). Studies using 
young rodents and non-human primates have shown that animals are susceptible to 
neurodegeneration when exposed to high concentrations of general anesthesia. This 
damage could cause learning delays, long term memory deficits, and spatial recognition 
impairment in the human population as well (Reddy, 2012). Additionally, studies that 
have examined infants and children exposed to large quantities of anesthetics have 
demonstrated increased difficulties in learning as well as more behavioral problems when 
compared to that of the general population of the same age (Reddy, 2012). There is 
currently, however, no available empirical evidence that describes how exposure to 
anesthesia in children under age four may lead to adverse effects on neurological 
development. Most of the current human research regarding anesthetic effects on the 
developing brain rely on retrospective studies, and existing databases, to review the long-
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term effects of anesthesia. Currently, studies such as the SMART Tots initiative are 
underway to explore how anesthesia affects human children and fetuses (Aker et al., 
2015). Although there are significant expenses and ethical dilemmas to consider in the 
design of large-scale research in this topic area, future evidence from large randomized 
control trials (RCTs) such as the SMART Tots study will hopefully paint a clearer picture 
on how anesthesia affects human subjects as the brain develops (Aker et al., 2015).   
As more and more gravid mothers and young children are undergoing general 
anesthesia for procedures, it is becoming vital to determine how anesthesia affects the 
developing brain. Studies that focus on inhalation agents, intravenous agents, and ways to 
protect the young brain are becoming more crucial. Knowledge generated from sound 
research is needed to determine the safest and most effective way to administer 
anesthesia to this vulnerable population. 
The purpose of this systematic review was to determine the effects of general 
anesthesia on the developing brain of fetuses and children age four and under. This 
systematic review comprehensively reviewed literature that focus on how anesthetics 
affect the developing brain.  
Next, a review of the literature will be presented. 
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Literature Review 
Potential damage caused by administering general anesthetics to the developing 
brain in young children and pregnant mothers is a hot topic among practicing anesthesia 
providers. This damage could cause learning delays, long term memory deficits, and 
spatial recognition impairment (Aker et al., 2015). In utero, the developing brain usually 
undergoes neuroapoptosis, defined as normal controlled cell death vital to brain 
development (Aker et al., 2015).  
 A literature search was completed using the keywords: "Brain development," 
"Anesthesia Effect on the Developing Brain," "Neuroapoptosis," and "Effects of Volatile 
Anesthetics."  CINAHL and PubMed were used to locate relevant literature for 
evaluation. The literature search was limited to retrospective studies, random controlled 
trials (RCT), and systematic reviews no older than the year 2011.  
Fetal Brain Development 
Of all the human organ systems, the brain is the most complex. It is made up of 
over 100 billion information processing cells known as neurons (Stiles & Jernigan, 2010). 
Neurons become created through the process of neurogenesis. These cells make up large 
networks that are responsible for thoughts, feelings, actions, and sensations (Stiles & 
Jernigan). Early in fetal development, brain tissue derives from the ectoderm, which 
begins as a neural plate on day 16 of gestation; by day 21 this tissue forms a neural tube 
(Chudler, 2015). The neural tube splits into three separate areas, including the forebrain, 
midbrain, and hindbrain. In the 7th week of development, the brain divides again through 
a process called encephalization, which increases the size and functionality of the brain. 
The majority of the brain development occurs during the prenatal period where the brain 
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will increase by 260% during the third trimester (Rothbaum et al., 2015). Between the 
last trimester and age three, the human brain sustains rapid development. Neurogenesis 
will continue after birth in the postnatal period, but to a much lesser degree (Stiles & 
Jernigan, 2010). Around 250,000 neurons are added every minute and become connected 
via synapses, a process known as synaptogenesis. By adult age, there are an estimated 60 
trillion neuronal connections (Stiles & Jernigan, 2010). 
The physiologic processes of synaptogenesis, neurogenesis, and gliogenesis allow 
the neurons to mature and differentiate. Synaptogenesis depends on constant neuronal 
signaling, communication, and feedback processing to create meaningful neuronal 
connections. During these developments, an overproduction of neurons, synapses, glial 
cells, and neural processes occurs (Stiles & Jernigan 2010). Neurons that are redundant or 
serve no purpose get pruned via neuroapoptosis.  
In order for these physiologic processes of brain development to occur, proper 
nutrition of the mother is warranted. Adequate intake of vitamins and minerals help 
promote adequate brain development. For example, iron plays a part in neuronal 
myelination and development of the frontal lobe in infants (Young, 2012). Another prime 
example is the intake of vitamin B12, which plays an essential role in neurologic and 
sensory developments (Rothbaum, Aly, & Massaro 2015). Without a balanced diet, a 
malnourished mother may produce children with smaller head circumference and lower 
brain weight which can contribute to an adverse neurodevelopmental outcome 
(Rothbaum et al., 2015).  
The brain is also susceptible to outside environmental factors that can cause 
adverse outcomes during development. A mother exposed to such things as lead, 
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mercury, and radiation exposure can result in reduced cognitive and motor skills in the 
child (Rothbaum et al., 2015). Lead, in particular, is known to injure developing neurons 
(Rothbaum et al., 2015). Drugs such as nicotine, alcohol, and cocaine ingested by the 
mother can be neurotoxic to the developing fetus resulting in lower intelligent quotient, 
developmental delays, and growth delays (Rothbaum et al., 2015).  
Excessive alcohol intake by the mother can lead to fetal alcohol syndrome in the 
infant, resulting in many disorders causing intellectual and behavioral impairments. 
These disorders are known as fetal alcohol spectrum disorders characterized by a wide 
range of teratogenic and psychological defects that can result in non-hereditary mental 
delays depending upon the amount of alcohol consumption (Parker et al., 2014). Even a 
small amount of alcohol ingestion during pregnancy is known to contribute to cognitive 
and behavioral issues. These issues include mood disorders, aggression and addictive 
behavior by negatively affecting neuronal and central nervous system development in 
utero (Parker et al., 2014). 
Animal studies are employed to ethically explore the effects of alcohol. For 
instance, Brocardo et al. (2017) studied Sprague Dawley rats exposed to ethanol during 
critical periods of brain development. The pregnant female rats separated into three 
cohorts represent their respective different trimesters. First-trimester pregnant rats 
(ETOH-1) were given a liquid diet in the first trimester which included 35.5% of their 
calories obtained from ethanol (Brocardo et al., 2017). Following the first trimester 
equivalent time, the ETOH-1 group ate a regular chow diet. Similarly, the second 
(ETOH-2) and third (ETOH-3) trimester rat groups received liquid foods containing 
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alcohol in their respective trimester, and chow for the other trimesters. Blood alcohol 
levels were also monitored throughout the pregnancy (Brocardo et al., 2017).   
The rat pups were sacrificed to examine the effects the ethanol had on brain 
tissue. It was found that oxidative damage was caused to the hippocampus of the ethanol-
exposed rat pups which contributes to developmental delays (Brocardo et al., 2017).  
There was also a decrease in the endogenous antioxidant glutathione levels in the 
hippocampus and cerebellum when exposed to EtOH. A two-way analysis of variance 
(ANOVA) revealed the effects of a developmental condition and period of exposure to 
alcohol as a significant interaction (F(2,70) =9.56, p < 0.01) (Broccardo et al., 2017). 
Analysis revealed total glutathione levels were significantly reduced in the ETOH-1 
group when compared to their controls (p < 0.01) within the hippocampus regions of CA 
and PFC (Brocardo et al., 2017).  Glutathione reduction is known to affect synaptic 
plasticity (Brocardo et al., 2017). Synaptic plasticity is the ability for synapses to weaken 
or strengthen and are vital to memory formation (Brocardo et al., 2017).  The results of 
this study indicate that there is no safe time in pregnancy to ingest alcohol, and by doing 
so can cause long-term alterations in brain function associated with fetal alcohol 
spectrum disorders (Brocardo, et al., 2017).  
The brain of the fetus is noted to be very fragile as it develops. It is susceptible to 
many outside influences and requires well-balanced nutrition by the mother. When 
exposed to teratogens such as drugs, environmental agents, and alcohol, neurotoxicity to 
the brain can occur leading to abnormal neuronal development and later cognitive delays. 
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Neurotoxicity  
  Neurotoxicity is a biological or chemical agent causing toxicity to the peripheral 
or central nervous system. It defines any adverse effect on the chemistry structure or 
function of the nervous system, during development or at maturity, induced by chemical 
or physical influences (Giordano & Costa, 2012). It is also categorized by reversible and 
irreversible brain damage, which could lead to neurocognitive deficits (Vilsides & Xie, 
2012). Neurotoxicity can cause changes in neurons (neuronopathy), axon degeneration, 
and the loss of glial cells around the axon (myelinopathy) (Giordano & Costa, 2012).  
  There are over 200 well-established chemicals that are neurotoxic to humans, including 
mercury, lead, and organophosphates, that can be neurotoxic to the fetus in utero 
(Giordano & Costa, 2012). Exposure to these chemicals prenatally and early postnatally 
possesses damaging influences on the structure of the nervous system (Giordano & 
Costa, 2012). These influences can lead to cognitive disabilities including learning 
disabilities and developmental delays.  
   Neurotoxicity related to Anesthesia. Anesthesia is known to cause neurotoxicity 
in some populations, particularly children and the elderly (Vilsides & Xie, 2012). 
Inhalation and intravenous anesthetics have been shown to cause neuroapoptosis, caspase 
activation, b-amyloid protein accumulation, and neurodegeneration in animals that can 
lead to cognitive defects (Vilsides & Xie, 2012). Drugs used in anesthesia can adversely 
affect neurotransmitters and receptors that are vital to brain development. This neurotoxic 
insult can disrupt brain development contributing to cognitive and behavior issues later in 
children exposed to anesthesia (Creeley, 2016). The importance of these receptors will be 
explored further in the discussion of neuroapoptosis.  
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Neuroapoptosis 
Apoptosis is a physiological process that targets cells to be phagocytized by 
macrophages in what is known as programmed cell death (Aker, Block, & Biddle, 2015). 
The mechanism of apoptosis can be categorized into four distinct phases: signaling, 
control and regulation, execution, and removal of the dead cell (Bennetts & Pierce, 
2010). The first phase, signaling, begins through a stimulus caused by tumor necrosis 
factor that triggers the apoptotic pathway, starting programmed cell death. The second 
control, and regulation, phase determines whether to commit or abort, apoptosis. If 
committed during this step there is no turning back. During the third stage of execution, 
the cell begins to break apart by proteolytic caspases. In the final stage, the cell is 
removed through phagocytosis by macrophages (Bennetts & Pierce, 2010).  
Neuroapoptosis is programmed cell death that is used to help control neuronal 
development. During neuroapoptosis, 50-70% of the excess neurons and synapses 
produced become phagocytized. The brain contains receptors, such as N-methyl-D-
aspartate (NMDA) and g-aminobutyric acid (GABAA) that are vital to normal neuronal 
development (Aker, Block, & Biddle, 2015). N-methyl-D-aspartate, an excitatory 
neurotransmitter, plays a significant role in learning and memory formation. During early 
brain development, the major inhibitory neurotransmitter GABA is also excitatory. This 
neurotransmitter is vital for neurogenesis and neuronal proliferation (Wu & Sun, 2015). 
During this critical time of development, the brain's receptors are susceptible to outside 
influences. Drugs, alcohol, and medications, such as those used in modern anesthesia, can 
disrupt the programmed cell death of neuroapoptosis. If the errant neurons are not pruned 
adequately via neuroapoptosis, long-term cognitive disability and brain malformation 
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could occur causing a lifetime of intellectual disability that includes both cognitive and 
behavioral effects (Creeley, 2016). 
Wilder et al. (2009) conducted a retrospective study to examine the long-term 
effects of anesthesia on children and learning disabilities. The authors hypothesized that 
similar to how alcohol exposure can cause changes in the developing brain, anesthesia 
may also contribute to adverse changes. The study included 5,357 children; of which 593 
of the children exposed to anesthesia before age four. Investigators found that for those 
who had a single exposure to anesthesia (n=449) it did not increase their chance of 
developing a learning disability (adjusted hazard ratio 1.00; 95% CI, 0.79 –1.27). 
However, those (n=144) that were exposed to two anesthetics (adjusted hazard ratio 1.59; 
95% CI, 1.06-2.37) or to three or more anesthetics (adjusted hazard ratio 2.60; 95% CI, 
1.60-4.24) significantly increased their risk factor (p < 0.001) for developing a learning 
disability. These risk factors include deficiencies in reading, writing, and mathematics 
(Wilder et al., 2009). Additionally, the estimated risk increased from 20% to 35% for 
development of a learning disability by age 19 in those children exposed to multiple 
doses of anesthesia versus children without anesthesia exposure (Wilder et al., 2009).  
The authors concluded that multiple exposures to general anesthesia could lead to 
learning disabilities caused by impairment of neural development. 
Anesthesia: Overview  
Anesthesia is defined as insensitivity to pain, especially as artificially induced by 
the administration of gases or the injection of intravenous drugs before surgical 
operations (Butterworth, Mackey, & Wasnick, 2014). The term anesthesia was first used 
by the Greek philosopher Dioscorides to describe narcotic-like effects caused by the plant 
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mandragora (Butterworth, Mackey, & Wasnick, 2014). Later the term was used by Oliver 
Wendell Holmes to include a state of amnesia, analgesia, and narcosis to make pain free 
surgery possible (Butterworth et al., 2014). There are several types of anesthetics 
including inhalation anesthetics and intravenous anesthetics that combine to make up 
general anesthesia. General anesthesia uses a combination of drugs to produce a loss of 
consciousness. The combination of drugs causes muscle relaxation, analgesia, and 
amnesia to safely and effectively allow patients to withstand surgical procedures. 
Inhalation agents. Inhalation anesthesia was the first type of anesthesia used for 
surgery in the 1800s before the invention of the hypodermic needle. WTG Morton 
demonstrated the use of diethyl ether as the first general anesthetic in 1846 (Butterworth 
et al., 2014). Diethyl ether is the precursor to modern volatile inhalation anesthetics such 
as nitrous oxide, sevoflurane, desflurane, and isoflurane. These current gases are liquid at 
room temperature, allowing them to transport easily and are relatively cheap to 
manufacture. With the help of a vaporizer, these liquids evaporate quickly, making them 
ideal as an anesthetic gas. All of the volatile inhalation agents act on inhibitory 
neurotransmitters known as GABAA receptors in the brain (Garcia, Kolesky, & Jenkins, 
2010). Nitrous oxide sometimes referred to as "laughing gas," is a non-volatile anesthetic 
gas stored and administered from a gas cylinder. Nitrous oxide differentiates itself from 
other inhalation anesthetics in that it acts on NMDA receptors (Garcia et al., 2010). 
Intravenous agents. As the science of anesthesia has progressed, innovative 
types of administration developed as well. The use of intravenous medications was first 
introduced as a type of anesthetic in 1872 using the sedative Chloral Hydrate by Pierre 
Ore' (Butterworth et al., 2014). Drugs such as morphine, barbiturates, and 
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sedative/hypnotics are used today in many surgeries requiring anesthesia. These drugs 
can be used in combination with inhalation agents, or on their own as part of general 
anesthesia.  
One of the most common hypnotic intravenous anesthetic drugs is propofol. 
Propofol, when used for sedation, contains some amnestic properties. Its main effect is on 
that of GABAA, a vital neurotransmitter to neurodevelopment, on the brain. GABAA is the 
principal inhibitory neurotransmitter in the brain that propofol interacts with causing 
disassociation resulting in unconsciousness and retrograde amnesia (Shafer, Rathmell, & 
Flood, 2015). Intravenous anesthesia medications such as propofol have been found to 
adversely affect the developing brain in animals (Andropoulos, 2017). Some evidence 
suggests that specific intravenous anesthetic exposure in the developing fetus, and 
children, may alter the GABA receptors placing them at risk for neurodegenerative 
changes (Andropoulos, 2017).   
  There are additionally, adjunct intravenous medications used during general 
anesthesia including benzodiazepines such as, midazolam, diazepam, and lorazepam 
which have sedative effects that target GABA receptors (Garcia et al., 2010). Another of 
the commonly used intravenous anesthetics, Ketamine, alters the NMDA memory 
receptors which contribute to its anesthetic effects.  
One of the earliest studies focusing on the blockade of the NMDA receptor was 
completed by Ikonimidou (1999). The purpose of this study was to determine if the 
blocking of NMDA receptors in parturient mothers, when exposed to certain anesthetic 
agents, affected the neuronal development of the fetus or neonate. Ikonimidou (1999) 
studied seven-day-old rat pups exposed to phencyclidine (PCP), carboxy pierazin-4-yl-
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propyl-2-phosphoric acid (CPP), and Ketamine. The rat pups were exposed to a steady 
state of each of these drugs over 8 hours (Ikonimidou, 1999). After sacrificing the rats, 
the authors used electron microscopy of the tissues to find that the exposure caused cell 
degeneration in the rats by altering neuroapoptosis (Ikonimidou, 1999). These findings 
suggest that fetuses and infants exposed to Ketamine and Nitrous Oxide during anesthesia 
could be at risk for neurodegeneration of the developing brain.  
In summary, the concern that neurotoxicity of general anesthesia to the 
developing brains of infants and fetuses continues to be a pressing issue among providers. 
Evidence through animal trials and retrospective studies shows a potential detriment to 
this vulnerable patient population.  As the surgical interventions on this population 
increase the number of research increases. 
Next, the discussion of the theoretical framework. 
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Theoretical Framework 
Nursing is a profession that uses many different theoretical approaches to guide 
nursing practice. One such theorist, Betty Neuman, is known for The Neuman Systems 
Model of Nursing. While working on her education, she developed her model while 
lecturing at UCLA. "A Model for Teaching the Total Person Approach to Patient 
Problems" was first published in 1972 and would soon develop into "The Neuman 
Systems Model" used by nursing programs around the world (McEwen & Wills, 2014). 
  In Neuman’s System, humans are described as a composite of interacting 
variables; physiological, psychological, sociocultural, developmental, and spiritual. These 
variables promote homeostasis. Neuman's version of homeostasis describes a structure of 
concentric rings, which represent three environments; internal, external, and created, all 
of which may help a person adapt to stressors (McEwen & Wills 2014, p. 152). Neuman 
describes the stressors as intra, inter, and extra personal in nature. Intrapersonal stressors 
happen internally, for example, infection, thoughts, and feelings. Interpersonal stressors 
occur from an individual's interaction with surrounding people. Extra personal stressors 
arise outside of the individual and include such examples as finances and jobs.  Lines of 
defense are set up around an underlying structure or central core of a person to protect 
from these stressors. These basic structures, which are common to all organisms, are 
normal temperature range, genetic structure, response pattern, organ strength or 
weakness, and ego structure (McEwen & Wills 2014, p. 152).   
  Neuman terms the first line of defense as the Flexible Line of Defense. This outer 
line of the defense protects the human being from stressors. The second line of defense is 
the Normal Line of Defense which adapts over time to keep the person in reasonable 
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health. The final line of defense or Lines of Resistance, such as a person's immune 
system, stabilizes the person back into wellness (Neuman & Fawcett, 2009). These 
defenses protect a person from environmental factors and stressors, in turn, maintaining 
wellness using a method of constant adaptation.  
Another concept Neuman includes in the theory is prevention: primary, 
secondary, and tertiary prevention. Primary prevention is the use of knowledge to reduce 
the effects of environmental factors before causing a reaction. Secondary prevention 
studies symptoms following exposure to stressors and uses interventions to decrease the 
possible effects while tertiary prevention uses an adjustive process and maintenance 
factors to return the person to a state of primary prevention. 
The Neuman Systems Model can apply to how anesthesia affects the developing 
brain. During procedures requiring anesthesia, the lines of defense are penetrated causing 
detriment to the developing brain. This environmental factor creates an extra personal 
stressor the body was not prepared to undergo. Once in the system, the anesthesia 
becomes an intrapersonal stressor, which could cause neurotoxicity leading to cognitive 
impairment. If cognitive impairment occurs from this invasion, other stressors can 
develop. 
Neuman's primary prevention concept is the best defense against adverse effects 
of anesthesia on the developing brain. Primary prevention is used to reduce risk factors 
for patients before the start of treatments. With increased knowledge of how anesthesia 
contributes to cognitive impairment, research and trials can determine which modalities 
of anesthesia cause the least amount of damage. Once established the treatment plan can 
be used in vulnerable populations protecting the brain from impairment before it occurs. 
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Even though Neuman's Systems model isn't very parsimonious, it can be shaped 
to a variety of nursing situations whether it is how extra personal stressors wreak havoc 
on a patient's diabetes or how anesthesia affects the developing brain the model can 
determine how to reduce these stressors maintaining wellness in an individual. 
Next, the Methods will be discussed 
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Method 
Purpose 
 The purpose of this systematic review was to determine the potential adverse 
effects of anesthesia on the developing brain in an unborn human fetus and infant. This 
review considers the following question: In children and fetuses of mothers undergoing 
general anesthesia, what are the adverse effects of the perioperative medications on the 
developing brain? 
Search Strategy 
  The literature search was conducted using the CINAHL and PubMed online 
databases simultaneously. The search term used was "effects of anesthesia," which 
yielded over 100,000 hits.  By using the terms "effects of anesthesia on the developing 
brain"  in the search engine results narrowed to 243 articles. The level of evidence and 
pertinence determined the number of articles used, based on inclusion and exclusion 
criteria listed below. Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) was developed and finalized in 2009 as a critical appraisal tool to 
help authors develop systematic reviews (Moher, 2009). This critical appraisal tool 
includes a checklist 27-item checklist and a four-phase flow diagram utilized to minimize 
bias, provide reliable findings, and allow accurate conclusions to be drawn from the 
collection of studies reviewed. Examples of the original checklist and flow diagrams can 
be found in Appendix A. Articles meeting the criteria were evaluated using the PRISMA 
flow diagram located in the results section for inclusion eligibility. 
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Inclusion Criteria 
  The literature search articles will be evaluated by relevance according to the 
purpose, intervention, and outcomes (PIO) design. The inclusion criteria will focus on 
studies containing randomized clinical control trials conducted within the last ten years. 
The clinical control trials will focus on the effects of anesthesia administered to young 
rats and mice to evaluate the impact on the developing brains of the human population.  
Exclusion Criteria 
Exclusion criteria consisted of non-English written articles and articles older than 
ten years. Subjective non-scientific articles were also dismissed.  
Data Collection  
 The articles reviewed determined useful and relevant data. Data collected 
included results from randomized control trials using primarily animal models such as 
rodents.  The effects of anesthesia on rodent models were classified and organized using 
two tables. The second table consists of data collection, results, limitations and 
conclusions. 
Table 1 
Data Collection Tool 1 
Purpose Study Design Subject Demographics Methods Measurement 
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Table 2 
Data Collection Tool 2 
Data Analysis Results Limitations Conclusions 
    
    
    
    
 
Outcomes specific to the effect on cognitive development after anesthesia was the 
primary data collected. The articles focused on how intravenous and volatile gas 
anesthetics affect the brain as the child develops in and out of the womb. The articles 
explored cognitive defects such as memory and spatial reasoning by studying animals, 
particularly rodents, using random control trials and real-time studies on rat pups exposed 
to the anesthesia agents. The information gathered from these articles was used to form 
results indicating the best type of anesthesia to use for fetuses and young children, and 
what can be done to avoid any adverse effects of anesthesia during surgery. 
Data Synthesis and Cross Study Analysis 
The data collection tools created were used to gather information from the 
19 
randomized control trials examined in this systematic review. A cross study analysis was 
then performed through creation of a comparison table that evaluated the studies by 
Behavioral Analysis Results, Histological Study Results, and Neurodegeneration Results. 
Data was then depicted in the table below (Table 3) with results described later in this 
systematic review (Appendix E). 
 
Table 3 
Author/Year/Anesthetic  Behavioral Analysis 
Results 
Histological Study 
Results 
Neurodegeneration Results 
  
 
  
  
  
  
 
Critical Appraisal 
The Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines 
for Randomized Control Trials, which is specific to animal studies was used to verify the 
relevance, integrity, and results of the articles utilized in this review. Each article was 
reviewed individually using the ARRIVE questionnaire checklist specific to animal 
research studies. The ARRIVE guidelines consist of a checklist of 20 items describing the 
minimum information that all scientific publications reporting research using animals 
should include (Kilkenny et al., 2010). Table 4, included below shows the ARRIVE 
grading system used to evaluate the studies reviewed. 
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Table 4 
 
 
 
 
 
Item # 
 
 
Arrive Grading System 
                     Recommendation 
Title 1 Provide as accurate and concise a description of the content of the article as possible. 
0= inaccurate 
1= accurate 
Abstract 2 
 
Provide an accurate summary of the background, research objectives, including 
details of the species or strain of animal used, key methods, principal findings and 
conclusions of the study. 
0= inaccurate 
1= accurate 
Background 3 a. Include sufficient scientific background  
to understand the motivation and context for the study and explain the 
experimental approach and rationale. 
b. Explain how and why the animal species and model being used can address 
the scientific objectives and, where appropriate, the study’s relevance to 
human biology. 
0= sufficient 
1= insufficient 
 
Objectives 4 Clearly describe the primary and any secondary objectives of the study, or specific hypotheses being tested. 
0= Clear 
1= Not Clear 
Methods 
Ethical 
statement 
5 Indicate the nature of the ethical review permissions, relevant licences and 
national or institutional guidelines for the care and use of animals, that cover the 
research. 
0= Clear 
1= Not Clear 
Study design 6 For each experiment, give brief details of the study design including: 
-The number of experimental and control groups. 
-Any steps taken to minimise the effects of subjective bias when allocating 
animals to treatment (e.g. randomisation procedure) and when assessing results 
(e.g. if done, describe who was blinded and when). 
-The experimental unit (e.g. a single animal, group or cage of animals). 
0= Clear 
1= Not Clear 
Experimental 
Procedures 
7 For each experiment and each experimental group, including controls, provide 
precise details of all procedures carried out. 
0= Clear 
1= Not Clear 
Experimental 
Animals 
8 Provide details of the animals used, including species, strain, sex, developmental stage, and weight.  
0= Clear 
1= Not Clear 
Housing and 
Husbandry 
9 Housing: type 
Husbandry: breeding, light/dark cycles, temperature, etc. 
0= Clear 
1= Not Clear 
Sample size 10 Number of animals used in each experiment. 0= Clear 1= Not Clear 
Animal Group 
Allocations 
11 -Give full details of how animals were allocated to experimental groups, 
including randomisation or matching if done. 
-Describe the order in which the animals in the different experimental 
groups were treated and assessed. 
0= Clear 
1= Not Clear 
Experimental 
outcomes 
12 Clearly define the primary and secondary experimental outcomes assessed (e.g. cell death, molecular markers, behavioral changes). 
0= Clear 
1= Not Clear 
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Next is a discussion of the Results 
 
  
 
 
  
Statistical 
methods 
13 -Provide details of the statistical methods used for each analysis. 
-Specify the unit of analysis for each dataset (e.g. single animal, group of 
animals, single neuron). 
-Describe any methods used to assess whether the data met the assumptions 
of the statistical approach. 
0= Clear 
1= Not Clear 
Baseline data 14 For each experimental group, report relevant characteristics and health status of animals (e.g. weight, microbiological status, and drug or test naïve) prior to 
treatment or testing. (This information can often be tabulated). 
0= Clear 
1= Not Clear 
Numbers 
analyzed 
15 -Report the number of animals in each group included in each analysis. 
Report absolute numbers (e.g. 10/20, not 50%2). 
-If any animals or data were not included in the analysis, explain why. 
0= Clear 
1= Not Clear 
Outcomes & 
estimation 
16 Report the results for each analysis carried out, with a measure of precision (confidence interval). 
0= Clear 
1= Not Clear 
Adverse events 17 -Give details of important adverse events in each experimental group. 
-Describe any modifications to the experimental protocols made to reduce 
adverse events. 
0= Clear 
1= Not Clear 
Interpretation/ 
scientific 
implications 
18 -Interpret the results, taking into account, the study objectives and 
hypotheses, current theory and other relevant studies in the literature. 
-Comment on the study limitations including any potential sources of bias, any 
limitations of the animal model, and the imprecision associated with the results. 
-Describe any implications of your experimental methods or findings for the 
replacement, refinement or reduction (the 3Rs) of the use of animals in research. 
0= Clear 
1= Not Clear 
 
Generalizability/ 
translation 
19 Comment on whether, and how, the findings of this study are likely to translate to other species or systems, including any relevance to human biology. 
0= Clear 
1= Not Clear 
 
Funding 20 List all funding sources (including grant number) and the role of the funder(s) in the study. 
0= Clear 
1= Not Clear 
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Results 
Prism Flow Diagram 
 
The PRISMA flowchart above, along with the inclusion and exclusion criteria 
discussed in the methods section were used to narrow down, and ultimately determine 
articles appropriate for the systematic review. A total of eight articles were determined to 
be duplicated in both databases and were discarded. After reviewing the titles and 
abstracts further elimination of articles occurred using the previously stated exclusion 
 
n = 140) 
 
 
Records after duplications 
removed: (n= 235) 
Records screened by 
Title/Abstract: (n= 235 ) 
Records excluded: 
(n= 214 ) 
Full-text articles assessed 
for eligibility: (n= 21) 
Full-text articles 
excluded with reasons: 
(n=17) 
Studies included in 
qualitative synthesis: (n=4 ) 
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criteria. This ultimately brought the total number of articles to 21. The study articles were 
further narrowed down to four in total by using both exclusion and inclusion criteria. The 
exclusion criteria consisted of non-English written articles, articles older than ten years, 
and subjective non-scientific articles, while the inclusion criteria encompassed 
randomized control trials. 
 O’Farrell, Foley, Bugger, & Gallagher (2018) conducted a randomized control 
trial using 15-day old Wistar rat pups to evaluate the neurotoxic effects of inhalation 
agents. This experimental study exposed the rats to urethane, isoflurane and sevoflurane 
(Note: Urethane was admitted as an outcome criteria in this systematic review, as it is not 
currently being used as an anesthetic in humans). All animals were administered either 
the anesthetic or a placebo (O’Farrell et al., 2018). The rats were then tested at 48 hours 
and 96 hours for behavioral and histological analysis (Appendix B, table B-1). 
O’Farrell et al. (2018) determined that in rats exposed to the volatile anesthetic 
gases: sevoflurane and isoflurane, demonstrated enhanced excitability through a number 
of behavioral parameters. The behavioral parameters observed included activity, 
grooming, rearing, and suckling (O’Farrell et al., 2018). Activity and locomotion 
included observation on how much each subject moved in an enclosed activity box. The 
activity parameters were averaged based on the time the animal spent moving and the 
percent of time active (O’Farrell et al., 2018). Grooming and rearing behavioral 
parameters included comparisons of how much time the mother would groom and spend 
time with the rat pup after anesthesia exposure versus a control group. The suckling score 
was calculated by monitoring the time the rat pups spent feeding on their mother 
24 
(O’Farrell et al., 2018). By observing these behaviors in the rat pups exposed to 
sevoflurane and isoflurane, versus a control group, researchers could determine if any 
insults to the brain occurred. The observations took place at 48 and 96 hours post 
exposure. 
Results related to animal behavior were reviewed at 48 and 96 hours (Appendix 
C, Table C-1). At 48 hours post exposure there was little clinical difference found in the 
activity parameter in the sevoflurane and isoflurane exposed animals, when compared to 
the control. Scores of 11.7 +/- 2.7 were awarded for sevoflurane and 9.38 +/- 3.21 for 
isoflurane versus the control score of 9.9 +/- 1.66 with a p value of 0.03. However, there 
was a notable increase at 96 hours post exposure (O’Farrell et al., 2018).  With 
sevoflurane scoring  15.8 +/-  1.56 and Isoflurane scoring 15.4 +/- 2.03 versus the control 
group at a score of 11.2 (p = 0.02) (O’Farrell et al., 2018). Suckling scores for the 
sevoflurane group were significantly decreased at 48 hours 1.67 +/- 0.33 compared to the 
control group of 3.20 +/- 0.53 (O’Farrell et al., 2018). At 96 hours Sevoflurane continued 
to decrease to 0.89 +/- 0.26 versus the control groups score of 2.42 +/- 0.36 (O’Farrell et 
al., 2018).  Isoflurane exposed rats only saw a significant decrease in suckling scores of 
1.13 +/- 0.23 at 96 hours when compared to the control group (O’Farrell et al., 2018). 
Rearing scores for sevoflurane (1.67 +/- 0.33) exposed rats decreased compared to 
controls (3.20 +/- 0.53), whereas the isoflurane group (2.63 +/- 0.37) demonstrated little 
difference compared to the baseline control group (p = 0.04) (O’Farrell et al., 2018). 
O’Farrell et al. (2018) also evaluated histological studies, such as total cell counts 
located in the piriform cortex of the volatile anesthetic exposed rats (Appendix C, Table 
C-1). By counting the number of dying cells in this cortex, O’Farrell et al. determined the 
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amount of neurodegeneration that occurred in the brain tissue of the exposed rats. Again, 
using the time of 48 hours post exposure and 96 hours post exposure, harvested brain 
tissue was examined to count the total cells present in the layers of the piriform cortex.  
Total cell counts were calculated in layer II of the piriform cortex for each of the 
rats exposed to volatile anesthetics (O’Farrell et al., 2018). A mean +/- SEM value was 
calculated for each exposed group (O’Farrell et al., 2018). At the 48-hour time point both 
the isoflurane and sevoflurane group (p = 0.03) demonstrated an increase in total apoptic 
cells in comparison to the control group.  There was no significant change between the 
sevoflurane group when compared to the control group at 96 hours (O’Farrell et al., 
2018). Isoflurane had a significant reduction in total cells in the brain at 96 hours post 
exposure (p = 0.03) (O’Farrell et al., 2018). The results in this study demonstrated that 
isoflurane damaged a larger amount of tissue leading to neurotoxicity, resulting in more 
harm than sevoflurane to the developing brain. 
Using the ARRIVE guidelines it was determined that O’Farrell et al. (2018) 
lacked a clear ethical statement from the authors. Funding of the study also was not 
disclosed. Furthermore, the paper also failed to divulge details on the how the rats were 
housed during the experiments. Deficiencies in these categories resulted in a score of 
zero. 
Tao et al. (2016) aimed to determine if isoflurane or desflurane caused more harm 
to the developing brain by creating a randomized control trial using three groups of 119 
six-day-old mice: a control group, isoflurane group, and a desflurane group (Appendix B, 
Table B-2). After being subjected to their respective anesthetic groups the mice were 
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placed in two experiments in addition to brain harvesting to determine the effects of the 
anesthetics, isoflurane and desflurane, on spatial reasoning and memory. The mice were 
divided equally among the litters to minimize differences associated with different 
mothers. Mice that had been exposed to these volatile gases were put through learning 
and memory condition testing including the Morris water maze (MWM) and a fear 
conditioning test (FCT) (Tao et al., 2016). Prior to volatile gas exposure the MWM trials 
mice were placed in a small pool and investigators determined how fast it took them to 
reach a hidden platform. Once they learned how to find the platform the mice were then 
divided into a control group, isoflurane group, and desflurane exposed groups. After 
exposed to their respective anesthesia, the mice would then take the MWM again (Tao et 
al., 2016). 
During the MWM test escape latency was measured over seven days. Escape 
latency was determined by calculating how long it took the mice to cross platforms (Tao 
et al., 2016). Each day they were put in the tank the mice would remember and learn what 
to do and the times would improve. The data was gathered (Appendix C, Table C-2) and 
it was determined that escape latency times of mice treated with isoflurane for 2 h daily 
for 3 days were significantly higher than those recorded for mice that were treated only 
with the control group of oxygen. A two-way ANOVA test with repeated measurements 
found there was a significant effect on escape latency times with mice treated with 
isoflurane at the P < 0.05 confidence level for the conditions versus mice in the oxygen 
control group [F = 2.734, p = 0.0153] (Tao et al., 2016).  However, there were no 
significant differences in escape latency times (MWM test) with mice treated with 
desflurane versus the control group [F = 0.3291, p = 0.9206] (Tao et al., 2016). The 
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results determined that mice with multiple exposures to isoflurane versus multiple 
exposures to desflurane contributed to causing long-term spatial learning and memory 
impairment (Tao et al., 2016).   
 In the fear conditioning test (FCT) mice were placed in a chamber and allowed to 
roam freely (Tao et al., 2016). After three minutes a tone would sound and a mild foot 
shock would be administered to the mouse (Tao et al., 2016). Forty-eight hours after the 
initial chamber exposure, and foot shock, the mice were placed in the chamber again. 
During this period, referred to as a context test, the mice would be placed in the chamber, 
and freezing times were recorded without a tone or shock (Tao et al., 2016). Freezing 
times were the amount of time the mouse would stay still after the sound of the tone. This 
was done to determine the ability of each mouse to contextually learn that placement in 
this environment indicated an impending shock could be coming and the mice would 
freeze. During the cue test, a tone would sound and no shock would be administered. The 
cue or tone would signal that an impending shock was possible. Investigators recorded 
the time for the mice to freeze with anticipation of an incoming shock. It was noted that 
the isoflurane exposed mice froze less (30 seconds) during the context test, whereas 
desflurane and control groups remained the same (50 seconds).  These findings 
(Appendix C, Table C-2) established that three exposures to isoflurane and not desflurane 
decreased the freezing times during the contextual FCT (p = <0.01) (Tao et al., 2016). 
However, there was no change noted in any group during the cue test, with all three 
groups freezing for approximately 50 seconds (Tao et al., 2016). 
Histological studies completed by Tao and colleagues (2016) examined the 
hippocampus of the mice to determine the effects isoflurane and desflurane had on 
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tissues. Tao et al. were specifically concerned with how the gases effected the 
phosphorylation of Akt, a protein kinase, and glycogen, a synthase kinase 3B (GSK3B). 
These kinases play a vital role in normal brain development and memory. 
Phosphorylation can cause functional suppression of these kinases. By decreasing 
phosphorylation learning and memory formation is affected.  
Using western blot analysis, Tao et al. was able to examine the amount (%) of 
phosphorylation that occurred in the hippocampus of the mice. During the analysis it was 
determined that three exposures to isoflurane, but not desflurane, decreased the 
expression of these kinases by 50% when compared to the control group (p < 0.01). This 
demonstrates that multiple exposures to isoflurane affects learning and memory by 
increasing neurotoxicity. 
Tao et al. (2016) also investigated the use of lithium as a pretreatment for the mice 
before isoflurane exposure to determine if it can reverse the effects on learning and memory 
impairment. A two-way ANOVA test found that lithium administered 30 minutes before 
isoflurane exposure effectively decreased escape latency times in mice treated with 
isoflurane compared to a group just receiving saline as a control [F = 1.741, p = 0.0332] 
(Tao et al., 2016). Tao et al. (2016) also evaluated whether lithium could reverse the 
reduced levels of Akt, GSK3B, and Beta-actin. This experiment was conducted using three 
groups; a control group, an isoflurane exposed group, and a lithium pretreated isoflurane 
group. One-way ANOVA indicated that lithium pretreatment was able to reverse the 
decrease in p-Akt (p < 0.05) and GSK3B (p < 0.01) phosphorylation suggesting that lithium 
can reverse isoflurane neurotoxicity. 
The evaluation of the Tao et al. (2016) study using the ARRIVE guidelines determined the 
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study was deficient in certain categories. There was a lack of information on how the 
animals were allocated to which group in the study. There was also a lack of translation 
and what the results would mean in the human population when exposed to the anesthetics. 
Tao et al. (2016) also failed to clearly define how their study was funded. 
Wu, Wang, Guo, & Zhang (2018) investigated how the NMDA receptor 
antagonist, ketamine, effects neuroapoptosis both by itself, and under hyperoxic 
conditions (Appendix B, Table B-3). Investigators also examined the effect ketamine and 
hyperoxia had on paO2 levels (Wu et al., 2018). The randomized control trial study used 
7-day-old rat pups allocated into four groups: control, hyperoxia, ketamine, and ketamine 
plus hyperoxia (Wu et al., 2018). The control group was injected with saline whereas the 
ketamine included groups received subcutaneous injections of 50 mg/kg of ketamine. The 
hyperoxic group and ketamine plus hyperoxic group were exposed to higher levels of 
oxygen (60%) for 2 hours (Wu et al., 2018). 
The NMDA glutamate receptor is a ligand-gated ion including an NR-1 subunit 
that is vital to normal brain growth and development. Wu et al. (2018) aimed to 
determine how much ketamine would affect neuroapoptosis (Appendix C, Table C-3). 
Hyperoxic exposed rat pups (paO2  242.3 +/- 12.7 mmHg) and ketamine plus hyperoxic 
exposed rat pups (paO2  244.7 +/- 9.1 mmHg)  demonstrated an increase in paO2 levels 
when compared to the control (paO2 89.8 +/- mmHg) (Wu et al., 2018). Pups exposed to 
just hyperoxic conditions, exposure to 60% oxygen for two hours, demonstrated apoptic 
scores similar to the control group (< 5 %). Pups exposed to ketamine without hyperoxia 
were found to have increased apoptosis (30%) when compared to the control pups (p < 
0.01) (Wu et al., 2018). While pups exposed to ketamine with hyperoxia showed more 
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apoptosis than pups receiving ketamine alone (55%) (p < 0.01) (Wu et al., 2018). The 
results indicate that ketamine, with or without hyperoxia, can affect expression of the 
NR-1 subunit which leads to an increase in neuronal apoptosis. 
Using the ARRIVE guidelines to evaluate Wu et al. (2018) it was determined the 
study was deficient in two categories. Translation of the results to the human population 
when exposed to the anesthetics studied was not provided. Wu et al. (2018) also failed to 
clearly define how their study was funded. Overall, the Wu et al. (2018) study scored 
well in the majority of the ARRIVE guidelines created by Kilkenny et al. (2010). 
The aim of the study conducted by Zheng, An, Cheng, & Wang (2013) was to 
investigate whether different lengths of exposure time and different concentration 
percentages of the volatile inhalation agent sevoflurane affected neuronal apoptosis in 21 
seven-day-old neonatal Wistar rats (Appendix B, Table B-4). The rats were randomized 
into five control groups. A control group, a group exposed to 1% sevoflurane for two 
hours, a group exposed to 1% sevoflurane for four hours, a group exposed to 2% 
sevoflurane for two hours, and a group exposed to 2% sevoflurane for four hours. Post-
anesthesia exposure subgroups were created that evaluated open-field tests and two 
immunohistology tests. Behavior and learning were tested at weeks five, eight, and 
fourteen after sevoflurane exposure.  
Results related to apoptosis, behavior, and memory were tabulated (Appendix C, 
Table C-4). Zheng et al. (2013) used an open field technique to determine excitability. 
The rats were placed in a 41 cm x 41cm x 41 cm acrylic table and movements were 
documented at 600 seconds (Zheng et al., 2013). At 8 weeks and 14 weeks the study 
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group that had been exposed to 2% sevoflurane for four hours showed an increase in 
movements and excitability compared to the control group (p < 0.05) (Zheng et al., 
2013). A Morris Water Maze trail like the one used by Tao et al. (2016) showed that 
regardless of time duration or percentage of exposure, sevoflurane exposed rats  showed 
no significant impairment of memory, or learning, when compared to the control group 
(Zheng et al., 2013).  
Through Western Blot Analysis, Zheng et al. (2013) examined the cleavage of 
PARP-1 cells in the hippocampus of the rats. The authors found that exposure to 2% 
sevoflurane for four hours induces cleavage of PARP-1 in the hippocampus of exposed 
rats (p < 0.05) versus the control group. Neonatal rat exposure to even the lowest 
sevoflurane 1% concentration induced apoptosis (Zheng et al., 2013). Capase-3 proteases 
along with PARP-1 play a central role in apoptosis. The more detected in the cells of the 
brain the more neurodegeneration (Zheng et al., 2013). Animals treated with sevoflurane 
exhibited dose and time dependent neurodegeneration. Capase-3 positive cells were 
detected in multiple areas of the brain, with the most vulnerable area consisting of the 
hippocampus (p < 0.05)  (Zheng et al., 2013).  These two immunohistology tests 
indicated that sevoflurane exposure at different dosage and exposure times can increase 
neuronal apoptosis in rats (Zheng et al., 2013). 
Reviewing the Zheng et al. (2013) article using the ARRIVE guidelines created 
by Kilkenny et al. (2010) found that the study was deficient in just two categories. 
Similarly, to the Wu et al. (2018) study this study failed to provide how the results would 
translate into the human population. The study also neglected to clearly define how the 
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funding for the study was achieved. Overall, the Zheng et al. (2013) study scored well in 
all the other ARRIVE guideline categories. 
The four articles examined in this systematic review scored fairly well in all 
categories within the ARRIVE guidelines with results tabulated in the table located in 
Appendix D. All four articles scored a zero in the funding column (item 20) as no articles 
gave clear definition on how their studies were funded. Zheng et al. (2013), Tao et al. 
(2016), and Wu et al. (2018) did not provide clear evidence on how their results could be 
translated into the human population resulting in a score of zero in that category (item 
19). O’Farrell et al. (2018) lacked a clear ethical statement (item 5) and details on the 
housing of the animals used for the experiment (item 9), resulting in a score of zero in 
those categories. Tao et al. (2016) and O’Farrell et al. (2018) failed to divulge how they 
chose to allocate the animals into specific study groups resulting in a score of zero for 
that class (item 11). Otherwise, the articles remained proficient in the remaining ARRIVE 
criteria created by Kilkenny et al. (2010).  
The studies used for this systematic review were evaluated using Table 3 with 
comparison results depicted in Appendix E. This table was used to cross analyze the 
articles in the topics of behavioral analysis, histologic study results, and 
neurodegeneration results. 
Within behavioral analysis it was noted by O’Farrell et al. (2018) and Zheng et al. 
(2013) that the anesthetics they studied, Sevoflurane and Ketamine respectfully, resulted 
in an increase in excitability in their subjects. Tao et al. (2016) did not find any increase 
in excitable activity in their subjects receiving isoflurane or desflurane; however, they did 
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note issues with long-term memory impairment and learning dysfunction in those rodents 
exposed to isoflurane. Wu et al. (2018) did not focus on behavioral parameters in their 
study. 
Histological analysis in all four studies uncovered an effect of anesthesia on 
normal functioning cells in the brain. For example, O’Farrell et al. (2018) found that 
during piriform cortical cell counts, there was a reduction in cells in those exposed to 
isoflurane and sevoflurane. Tao et al. (2016) showed a decrease in phosphorylation of 
Akt and GSK3B in Isoflurane exposed rats, but not in desflurane exposed rats. The Wu et 
al. (2018) study determined a higher mRNA and NR-1 subunit expression in those 
exposed to ketamine as well as ketamine + hyperoxia. Finally, Zheng et al. (2013) 
determined that exposure to the inhalation agent sevoflurane increased cleavage of  
PARP-1 in the hippocampus. Overall these studies demonstrate that based on histological 
findings abnormal cellular changes in the brain related to anesthesia can lead to 
neurodegeneration and effect neurological development. 
Interestingly, the findings from O’Farrell et al. (2018) suggest that sevoflurane 
induces less neurotoxicity than isoflurane. The number of apoptic cells during the counts 
at 48 hours post exposure to sevoflurane were 1.75 micrometer versus 2.25 micrometers 
in isoflurane. This result is indicative of isoflurane being more deleterious to the brain 
than sevoflurane. Tao et al. (2016) similarly noted that isoflurane has more detrimental 
outcomes than that of desflurane. Isoflurane was found to cause a reduction in 
phosphorylation of the enzymes Akt and GSK3B, which are vital to signaling pathways 
linked to brain and learning development. Wu et al. 2018 indicated that ketamine with, 
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and without, hyperoxia exposure increased neuroapoptosis. Apoptic cells of ketamine 
exposed rats increased by 35% in comparison to the control group. The Zheng et al. 
(2013) study determined that exposure to sevoflurane in neonatal rats induced apoptic 
neurodegeneration as a result of the cleavage of PARP-1 in the hippocampus. 
Ultimately, the review of the cross-study analysis determined that all anesthetic 
modalities reviewed in these four studies had some type of adverse effect. The effects 
were indicated in either behavioral analysis, histologic analysis, or in some level of 
neurodegeneration. These results determined that exposure to certain types of anesthesia 
can adversely affect brain development in rodent subjects. 
Next, is a discussion of the summary and conclusions. 
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Summary and Conclusions 
This systematic review intended to determine the effects of general anesthesia on 
the developing brain of children and unborn fetuses. Anesthetic agents and drugs can 
adversely affect the brain of children as it develops by disrupting normal neuroapoptosis. 
(Aker et al., 2015). Due to ethical concerns, such as brain harvesting for histological 
studies on the effects of anesthesia on the developing brain, randomized control trials 
using humans as subjects were not found. This systematic review of four random control 
trials provided evidence that the anesthetic agents studied: isoflurane, desflurane, 
sevoflurane, and intravenous ketamine, in some form or another altered normal apoptosis 
of rodents. As mentioned neuroapoptosis is the body's normal controlled cell death that is 
crucial in the role of brain development (Aker et al., 2015). Controlled cell death plays a 
vital role in neurodevelopment and helps to limit redundancy, faulty neurons, or unused 
neurons from crowding the developing brain (Creely, 2016). The effect of the 
neurodegeneration in these rodent studies led to the discovery of some adverse findings 
in learning and memory impairment, which may be equate to similar findings in humans. 
The CINHAL and Pubmed databases were utilized during this systematic review. 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses was used to 
analyze, limit bias and draw accurate conclusions of the articles allocated during the 
database search. Critical analysis and cross study analysis were completed using the 
Animals in research: reporting in vivo experiments (ARRIVE) for Randomized Control 
trials specific to animal studies. ARRIVE utilizes a checklist and grading scale to 
determine articles searched meet the minimum requirements of scientific studies using 
animals as subjects. 
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After reviewing the databases, four articles were chosen that focused on animal 
models which could be used to determine the effects of general anesthesia on developing 
brains. These studies demonstrated that volatile inhalation anesthetics, and some 
intravenous administrated anesthetics, currently used in anesthesia practice is linked to 
neurodegeneration and neurotoxicity in the developing brains of rodents.  
O’Farrell et al. (2018) demonstrated that rats exposed to just one dose of the 
inhalation agent isoflurane produced neurologic toxicity in their piriform cortex. Both 
isoflurane and sevoflurane exposed rats were also found to suffer from increased activity 
levels and decreased suckling times. Tao et al. (2016), was able to show that exposures to 
isoflurane, but not desflurane, induced learning and memory impairment in mice. Tao et 
al. (2016) point out that this may attributed to isoflurane’s effect on the Akt/GSK3ß 
signaling pathway, leading to neurotoxicity in the developing brain. Notably, it was 
further observed that lithium attenuated the effects of isoflurane, thus improving learning 
and memory (Tao et al., 2016). 
This is similar to the cognitive effects that environmental factors, such as alcohol 
or lead exposure can have on brain development. While isoflurane effected memory and 
learning impairment in rats, alcohol has been found to act comparably in exposed fetuses 
(Parker et al, 2014). O’Farrell et al. (2018) noted that isoflurane exposed rats had a 
decrease in suckling times, which results in improper feeding, inadequate nutrition and 
poor development. Likewise, children and unborn fetuses who don’t have adequate intake 
of vitamins and minerals are noted to have deficiencies in both neuronal myelination and 
frontal lobe development (Rothbaum et al., 2015; Young, 2012). Without the proper 
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nutrition from being able to feed, the anesthesia exposed rats suffer a similar 
developmental disadvantage.  
Wu et al. (2018) administered ketamine to seven-day-old rats under normal and 
hyperoxic conditions and compared this to a control group, and a hyperoxia only group. 
Wu et al. (2018) found that ketamine can cause abnormal neuroapoptosis in the 
developing rat brain, and this was further exacerbated under hyperoxic conditions. This 
was believed to be due to the effect of ketamine on NMDA receptor NR-1 expression 
(Wu et al., 2018). These findings provide evidence regarding the safety of ketamine 
administration alone, or under hyperoxic conditions, on the developing rat brain (Wu et 
al., 2018). Likewise, Ikonomidou (1999) study of seven-day-old rat pups exposed to 
ketamine for over 8 hours found neurological cellular degeneration and altered 
neuroapoptosis. Ikonomidou (1999) findings along with the results of Wu et al. (2018) 
indicates that the fetuses of parturient mothers, as well as infants, who receive ketamine 
could be subjected to neurodegeneration. However, neither study conducted a behavioral 
analysis on the exposed rats to determine if those traits could be translated into the human 
population. 
Zheng et al. (2013) examined the effects of sevoflurane, at different durations, on 
neuronal apoptosis, development, and adaptability of exposed rats. Zheng et al. (2013) 
found that higher dosages and longer duration of sevoflurane led to greater 
neuroapoptosis in exposed rats. It was also found that exposure to sevoflurane caused an 
increase in excitability, however, it was noted by Zheng et al. (2013) that spatial memory 
and learning was not affected in the rats exposed to sevoflurane. 
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The findings of Zheng et al. are in contrast to those of a retrospective study by 
Wilder et al. (2009). Wilder et al. determined that children exposed to not one, but 
multiple, doses of anesthetics were more likely to develop learning difficulties. Zheng et 
al. (2013) noted that more frequent and longer duration of exposure to sevoflurane 
affected excitability and neuroapoptosis, but not memory and learning. O’ Farrell et al. 
(2018), however, did note memory and learning impairment with isoflurane. These 
results indicate that it may not just be a dose and time dependent issue with anesthesia 
exposure in children and infants, but the type of anesthetic agent as well. 
Findings of the cross-study analysis in this systematic review revealed that two 
studies (O’Farrell et al., 2018; Zheng et al., 2013) demonstrated an increase in 
excitability in their subjects during behavioral analysis. Tao et al. (2016) noted issues 
with long-term memory impairment and learning dysfunction in rodents exposed to 
isoflurane. Similar changes in the brain leading to cognitive and behavior changes has 
likewise been noted in children exposed to alcohol during pregnancy (Parker et al., 2014). 
Comparably, environmental factors such as: mercury, radiation, or lead has also been 
found to reduce cognitive ability and motor skills in children (Rothbaum et al., 2015). 
Wu et al. (2018) did not focus on behavioral parameters during their study, which is 
unfortunate because behavioral analysis information regarding the behavioral effects of 
ketamine would be beneficial to anesthesia practice. 
The histological findings synthesized in the cross-study analysis reveals that all 
four studies, (O’ Farrell et al., 2018; Tao et al., 2016; Wu et al., 2018;  Zheng et al., 
2013), uncovered an anesthesia effect on normal functioning cells in the brain. All 
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histological findings show abnormal changes in the brain can lead to neurodegeneration 
and effect development of the brain. Due to ethical concerns cell study of the brain in 
children is unable to be completed. This is a limitation when trying to translate the animal 
study findings to that of the human population. Although the results of this review 
indicate strong evidence that anesthetic agents result in neurotoxicity in neonatal rodents, 
it is not possible to determine to what degree these results correlate to the developing 
human brain. Rodents develop at a much faster rate than children and the brains of 
humans are more complex when compared to rodents (Stiles & Jernigan, 2010).  
In conclusion, this systematic review provides evidence that rodents, such as mice 
and rats, exposed to various inhalation and intravenous anesthetic agents can have a 
negative impact on their developing brain. These unfavorable outcomes can lead to 
learning impairment and memory issues that could affect the rodents during their 
lifetime. While these articles provide evidence regarding how anesthesia can affect the 
developing brains of rodents, further study needs to focus on the developing brains of 
humans. There are significant expenses and ethical dilemmas to consider in the design of 
large-scale research in this topic area. Future evidence from large randomized control 
trials (RCTs) such as the SMART Tots, MASK, and PANDA studies will hopefully paint 
a clearer picture on how anesthesia affects human subjects as the brain develops.   
Next, Recommendations and Implications for Advanced Nursing Practice will be 
presented.
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Recommendations and Implications for Advanced Nursing Practice 
The field of Certified Registered Nurse Anesthetists (CRNA) is ever growing. 
These advanced practice nurses rely heavily on evidence-based research practices for 
continuing education in their area. Systematic reviews that summarize the most recent 
research available can be used as a tool to help advance safe practice. This information 
can be useful, to not only CRNAs, but for any advanced practitioner that interacts with 
the pediatric population. Knowing the patient’s anesthesia exposure history could be 
beneficial. If issues with learning and memory arise this information can be used to 
determine the best way to treat the individual. 
CRNAs that provide anesthesia to the pediatric population can take information 
from this review, and other studies, to determine the best type of anesthetic to administer. 
Even though this systematic review focused on rodent subjects the results indicate 
advantages and disadvantages to certain inhalation agents. For example, the study by 
O’Farrell et al. (2018) found that sevoflurane caused less neurotoxicity than isoflurane. 
Further Tao et al. (2016) determined that not only did isoflurane cause more 
neurotoxicity than desflurane, but that it also altered learning and memory. This evidence 
can better inform a provider to make a determination as to whether or not to avoid 
isoflurane when administering volatile inhalation agents to gravid mothers or infants. 
Further studies such as the project titled, SmartTots, which look at the long-term 
effects of anesthesia and determine its safety are needed (O’Farrell., (2018). Several 
studies, however, have been conducted that have focused on anesthesia exposed children 
and their intelligent quotient (IQ). The Mayo Anesthesia Safety in Kids Study (MASK) 
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studied the neurophysical and behavior outcomes of children after anesthesia exposure 
(Warner, Zaccariello, Katusic, Schroeder, Hanson, Schulte, & Flick, 2018). The 
intelligent quotient did not differ significantly. Single anesthesia exposed children had IQ 
scores an average 0.5 points lower (95% CI, p= 0.70) and multiple exposed children 
averaged 1.3 points lower (95% CI, p=0.32) (Warner et al., 2018).  It is important to 
note, however, that parents of the multiple exposure children in this study stated their 
children exhibited problems related to executive function, behavior, and reading (Warner 
et al., 2018). These stated secondary outcomes from the parents should be interpreted 
with caution. Another study conducted by Sun, Li, Dimaggio, Byrne, Ing, Miller, & 
Mcgowan (2012) called the PANDA study also reviewed IQ. This study focused on 
children that received anesthesia for hernia repair before age three and compared them to 
their siblings (Sun et al., 2012). The 28 children, aged 6 to11-years had no significant 
difference in IQ, but this study was limited by the number of pairs evaluated (Sun et al., 
2012).  
Current long-term studies involving human subject such as SmartTots may hold 
the answer to how anesthesia is practiced in the future. Additional random controlled trial 
studies focusing on the human pediatric patient are warranted. Future studies should be 
conducted comparing anesthesia modalities such as inhalation agents versus intravenous 
agents, or, versus regional. Evidence from such research may offer anesthesia providers a 
way to tailor their practice for the pediatric population. In the meantime, it is important to 
diligently stay educated on the newest research in this topic in order to safely administer 
anesthesia to this vulnerable population. 
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Appendix A 
PRISMA 2009 Checklist  
Section/topic  
 
#  
Checklist item  
 
Reported 
on page #  
TITLE   
Title  1  Identify the report as a systematic review, meta-analysis, or both.  
 
ABSTRACT  
 
Structured 
summary  2  
Provide a structured summary including, as applicable: 
background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis 
methods; results; limitations; conclusions and implications of 
key findings; systematic review registration number.  
 
INTRODUCTION  
 
Rationale  3  Describe the rationale for the review in the context of what is already known.  
 
Objectives  4  
Provide an explicit statement of questions being addressed with 
reference to participants, interventions, comparisons, outcomes, 
and study design (PICOS).  
 
METHODS  
 
Protocol and 
registration  
 
5  
Indicate if a review protocol exists, if and where it can be 
accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
 
Eligibility 
criteria  6  
Specify study characteristics (e.g., PICOS, length of follow-up) 
and report characteristics (e.g., years considered, language, 
publication status) used as criteria for eligibility, giving 
rationale.  
 
Information 
sources  7  
Describe all information sources (e.g., databases with dates of 
coverage, contact with study authors to identify additional 
studies) in the search and date last searched.  
 
Search  8  Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.  
 
Study selection  9  
State the process for selecting studies (i.e., screening, eligibility, 
included in systematic review, and, if applicable, included in the 
meta-analysis).  
 
Data collection 
process  10  
Describe method of data extraction from reports (e.g., piloted 
forms, independently, in duplicate) and any processes for 
obtaining and confirming data from investigators.  
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Data items  11  
List and define all variables for which data were sought (e.g., 
PICOS, funding sources) and any assumptions and 
simplifications made.  
 
Risk of bias in 
individual 
studies  
12  
Describe methods used for assessing risk of bias of individual 
studies (including specification of whether this was done at the 
study or outcome level), and how this information is to be used 
in any data synthesis.  
 
Summary 
measures  13  
State the principal summary measures (e.g., risk ratio, 
difference in means).  
 
Synthesis of 
results  14  
Describe the methods of handling data and combining results of 
studies, if done, including measures of consistency (e.g., I2) for 
each meta-analysis.  
 
 
PRISMA 2009 Checklist  
Section/topic  
 
#  
Checklist item  
 
Reported 
on page #  
Risk of bias 
across studies  15  
Specify any assessment of risk of bias that may affect the 
cumulative evidence (e.g., publication bias, selective reporting 
within studies).  
 
Additional 
analyses  16  
Describe methods of additional analyses (e.g., sensitivity or 
subgroup analyses, meta-regression), if done, indicating which 
were pre-specified.  
 
RESULTS  
 
Study selection  17  
Give numbers of studies screened, assessed for eligibility, and 
included in the review, with reasons for exclusions at each 
stage, ideally with a flow diagram.  
 
Study 
characteristics  18  
For each study, present characteristics for which data were 
extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
 
Risk of bias 
within studies  19  
Present data on risk of bias of each study and, if available, any 
outcome level assessment (see item 12).  
 
Results of 
individual studies  20  
For all outcomes considered (benefits or harms), present, for 
each study: (a) simple summary data for each intervention 
group (b) effect estimates and confidence intervals, ideally 
with a forest plot.  
 
Synthesis of 
results  21  
Present results of each meta-analysis done, including 
confidence intervals and measures of consistency.  
 
Risk of bias 
across studies  22  
Present results of any assessment of risk of bias across studies 
(see Item 15).  
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Additional 
analysis  23  
Give results of additional analyses, if done (e.g., sensitivity or 
subgroup analyses, meta-regression [see Item 16]).  
 
DISCUSSION  
 
Summary of 
evidence  
 
24  
Summarize the main findings including the strength of 
evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy 
makers).  
 
Limitations  25  
Discuss limitations at study and outcome level (e.g., risk of 
bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
 
Conclusions  26  Provide a general interpretation of the results in the context of other evidence, and implications for future research.  
 
FUNDING  
 
Funding  
 
27  
Describe sources of funding for the systematic review and 
other support (e.g., supply of data); role of funders for the 
systematic review.  
 
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
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Appendix B 
Table B-1 
 
O’Farrell, R. A., Foley, A. G., Buggy, D. J., & Gallagher, H. C. (2018). Neurotoxicity of Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior 
and Neurodegeneration in the Piriform Cortex. Anesthesiology Research and Practice,2018, 1-9. doi:10.1155/2018/6376090 
Purpose Study Design Subject 
Demographics 
Methods Measurement 
The aim of this 
study was to 
determine if 
volatile 
inhalation 
agents, 
isoflurane and 
sevoflurane, 
cause damage 
to the piriform 
cortex of rat 
pup brains as 
much as 
urethane.  
 
 
Random control trial  
using animal subjects with 
a control group. All 
animals were either 
administered a drug or a 
placebo. 
The rats were 
administered a single dose 
of anesthetic coinciding to 
their assigned groups. The 
delivery method of the 
anesthetic was determined 
by the preferred route of 
the drug. Injection for 
urethane and inhalation 
for isoflurane and 
sevoflurane. 
The control group was 
administered a placebo. 
 
15 Day postnatal 
male Wistar rats. 
15-day-old rats 
were used due to 
the fact that rats 
undergo a 
prominent brain 
growth spurt during 
this period of time. 
The rats were divided into three groups. Urethane 
n=21, isoflurane n=18, and sevoflurane n=18 
respectively.  
The rats were tested at 48 hours and 96 hours 
where behavior parameters were noted. After 
testing the rat pups were sacrificed and 
histological studies were performed to determine 
neurotoxic effects of the anesthetic agents 
The rats were kept normothermic through 
warming plates during the anesthesia delivery.  
Expired end-tidal gas analyzers were used to 
determine the appropriate amount of gas was 
delivered to the isoflurane (2.08%) and 
sevoflurane (3.4%) groups. The control group was 
administered urethane and saline intravenously. 
All rat groups FiO2 was maintained at 0.5. 
Anesthesia was administered to each group for 
four hours. 
Behavior analysis of neurotoxicity: 
each group was observed in an 
open field environment. The 
animals were studied for 5 minutes 
each and observations of 
vocalization, grooming habits, and 
locomotion/activity were noted. 
After the open-field observations 
the rats were returned to their 
mothers and observed for 30 
minutes: maternal grooming, 
vocalization, and suckling was 
noted. 
Histopathological studies: The rats 
were euthanized using sodium 
pentobarbitone. The piriform 
cortex from each rat in each group 
were then removed and sliced into 
6 segments. Frequency of injured 
and/or dying cells in each layer 
were observed and counted. 
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Appendix B 
Table B-2 
 
Tao. G, Xue, Q., Luo, Y., Li, G, Xia, Y., & Yu, B. (2016). Isoflurane is more deleterious to developing brain that desflurane: the told of AKT/GSK3ß  
 signaling pathway. BioMed Research International, 2016, 1-10. Doi:10.1155/2016/7919640 
Purpose Study Design Subject 
Demographics 
Methods Measurement 
The aim of this 
study was to 
determine if the 
inhalation 
anesthetic 
isoflurane, used 
in pediatric 
anesthesia, has 
more 
neurotoxic 
effects than 
desflurane. 
A Random controlled trial 
using three groups of mice. 
The mice were divided 
equally among the litters to 
minimized differences 
associated with different 
mothers. 
 
After being subjected to their 
respective anesthetic groups 
the mice were subjected to 
two experiments and brain 
harvesting to determine the 
effects of the anesthetics, 
isoflurane and desflurane, on 
spatial reasoning and 
memory. 
17 litters for a 
total of 119 Six-
day-old mice. 
Both genders 
utilized. 
 
The mice were 
housed at 
constant 
temperature with 
access to food 
and water. The 
mice were reared 
by their mother. 
 
 
 
The mice were divided 
into three groups. An 
isoflurane group, 
desflurane group, and a 
control group exposed 
to only oxygen and 
nitrogen.  
 
The mice were then 
divided as equally as 
possible into the 
various experiments. 
 
 
 
 At 31 days of age/post initial anesthesia dosages, all mice were 
placed in the Water Maze test (MWM). Escape latency times 
to evaluate spatial learning. 
Platform crossing times were measured during the MWM to 
determine spatial memory in each exposure group. 
 
Fear conditioning test (FCT) was used to determine fear 
conditioned memory. The mice were subjected to a sound and a 
mild shock. The mice were then retested using just the sound 
and freezing times  
were used to determine how conditioned the mice had become 
to the fear of being potentially shocked. 
The Freezing times were recorded to determine fear conditioned 
memory. 
 
Western blot analysis (WBA) was used  to determine 
hippocampus changes in harvested mouse brains exposed to 
anesthesia. The amount of 
phosphorylation of proteins associated with memory. 
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Table B-3 
 
Wu, C., Wang, J., Guo, X., & Zhang, Y. (2018). Ketamine exacerbates cortical neuroapoptosis under hyperoxic conditions by upregulating expression of the  
N-methyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC Anesthesiology,18(1). doi:10.1186/s12871-018-0511-y 
Purpose Study Design Subject 
Demographics 
Methods Measurement 
The aim of this study 
is to determine the 
possible effects of 
the NMDA receptor 
antagonist Ketamine 
and hyperoxia has on 
the developing brain. 
Specifically, the NR1 
receptor. 
 
 
 
Random control trial 
using rat pup models.  
Rats were allocated 
into four separate 
groups. 
• Control 
group 
• Ketamine 
group 
• Hyperoxia 
group 
• Ketamine + 
Hyperoxia 
group 
Seven-day-old male 
Sprague Dawley rat 
pups. Average weight 
of the pups was 12-
16 grams. The rats 
were obtained by the 
Peking University 
Health Center Ethics 
committee on Animal 
Care. 
N=72 
18 rats per group. 
Control group: received subcutaneous saline 
injections. 
Ketamine group: 50 mg/kg subcutaneous 
injections at room air (21%) 
Hyperoxia group: saline injections plus 60% 
oxygen administration. 
Ketamine + Hyperoxia group: Ketamine 50 
mg/kg injections plus 60% oxygen 
administration. 
 
Oxygen was administered to provide a hyperoxic 
state. The oxygen level was monitored 
continuously. Humidity was maintained > 80%. 
Excess CO2 was absorbed via soda lime. 
 
Arterial oxygen saturation and physical 
parameters were observed. 
Blood gas levels were obtained 
from each group two-hours 
after subcutaneous injections. 
 
Degree of apoptosis was 
measured using TUNEL assay 
and polymerase chain reaction 
(PCR). 
 
Western blot analysis was used 
to determine the amount of NR-
1 subunits were affected in 
each group. 
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Table B-4 
Zheng, S. Q., An, L. X., Cheng, X., & Wang, Y. J. (2013). Sevoflurane causes neuronal apoptosis and adaptability changes of neonatal rats. Acta 
Anaesthesiologica Scandinavica,57(9), 1167-1174. doi:10.1111/aas.12163 
Purpose Study Design Subject 
Demographics 
Methods Measurement 
The aim of this study 
was to determine if 
the increase in the 
concentration and 
duration of 
sevoflurane causes 
neurodegeneration 
and behavior changes 
as a rat develops. 
 
 
Randomized control 
trial of rat pups. 
 
Group 1: “Con” 
group-control 
Group 2: Sevo1%-2h 
exposed to 1% 
sevoflurane for two 
hrs. 
Group 3: Sevo1%-4h 
exposed to 1% 
sevoflurane for four 
hrs. 
Group 4: Sevo2%-2h 
exposed to 2% 
sevoflurane for two 
hrs. 
Group 5:  Sevo2%-4h 
exposed to 2% 
sevoflurane for four 
hrs. 
Post-natal day 7 
Wistar Rats 
raised by the 
Laboratory 
Animal Center of 
Academy of 
Military Medical 
Sciences in 
Beijing, China. 
 
 
 
 
Behavior and learning 
were tested at weeks five, 
eight, and fourteen after 
sevoflurane exposure. 
 
The rats were placed in an 
acrylic box and exposed to 
sevoflurane at different 
concentrations and 
duration. 
 
120 rats were divided into 
five separate groups of 
n=24. 
 
The total gas flow was 
2L/min using 100% 
oxygen and sevoflurane 
was monitored using the 
GE Dash 4000 anesthetic 
gas monitor. 
Brain matter harvested to determine effects of 
sevoflurane on apoptosis in the cortex and hippocampus. 
 
Post anesthesia rats were randomized into 3 subgroups  
 
Histopathologic analysis: N=6 perfused with 
paraformaldehyde and exposed for 24 hrs. at 4 degrees 
Celsius.  
 
Western Blot Analysis: Cortex and hippocampus from 
n=6 rats were removed and homogenized six hours post 
anesthesia. The segments were subjected to gel 
electrophoresis and the bands were analyzed by the 
software Gel-Pro analyzer to determine and neurological 
changes. 
 
Open-field test: Rats were placed on a table and 
movements were observed for 600 seconds.  
Morris Water Maze: Rats were placed in a pool of water 
and seeing how long it took them to find the platform in 
the center (latency). If unable to find the platform they 
were guided.  
 
54 
Appendix C 
Table C-1 
Outcome Data Collection 
O’Farrell, R. A., Foley, A. G., Buggy, D. J., & Gallagher, H. C. (2018). Neurotoxicity of Inhalation Anesthetics in the Neonatal Rat Brain: Effects on Behavior 
and Neurodegeneration in the Piriform Cortex. Anesthesiology Research and Practice,2018, 1-9. doi:10.1155/2018/6376090 
Data Analysis 
 
Results related to animal behavior Results related to apoptosis 
Data was entered into a 
database using GraphPad 
Prism v.4.0. The data was 
examined for distribution 
using the Kolmogorov-
Smirnov Test.  
 
Normally distributed data 
was compared using 
Analysis of Variance 
(ANOVA). 
 
Data was expressed as 
mean +/- SEM and 
P<0.05 was deemed 
statistically significant. 
 
No significant change in activity/locomotion, rearing, and suckling scores at 48 hours, but some 
changes noted at 96 hours for both sevoflurane and isoflurane exposed animals. 
 
Activity/Locomotion: increased in activity after exposure.  
Sevoflurane  score 11.7 at 48 hours versus 9.9 for control (p =  0.03). Score of 15.8 at 96 hours 
versus control (p = 0.02). 
Isoflurane score 9.38 at 48 hours versus 9.9 for control (p =  0.03). Score of 15.4 at 96 hours 
versus control (p = 0.02). 
 
Rearing: increased post exposure 
Sevoflurane score 6.78 at 48 hours versus 2.60 for control. Score of 7.56 at 96 hours versus 
control. (p = 0.04) 
Isoflurane score 3.38 at 48 hours versus 2.60 for control. Score of 4.25 at 96 hours versus control. 
(p = 0.04) 
 
Suckling: decreased post exposure 
Sevoflurane score 1.67 at 48 hours versus 3.20 for control. Score of  0.89 at 96 hours versus 
control. (p = 0.04) 
Isoflurane score 2.63 at 48 hours versus 3.20 for control. Score of 1.13 at 96 hours versus control. 
(p = 0.04) 
 
Piriform cell counts:  
 
Apoptic cell counts increased in 
urethane and isoflurane exposed 
rats. Sevoflurane exposed rats 
showed little difference compared to 
placebo. Counts were done using a 
mean ± SEM value. 
 
Statistically significant reduction in 
total piriform cell counts versus 
control (sevoflurane and isoflurane  
p = 0.03 and Urethane  p = 0.02). 
 
Statistically significant increase in 
apoptic cells versus control for 
(isoflurane  p = 0.04 and Urethane  
p = 0.03). However minimal to no 
change in the number of dying cells 
found in the sevoflurane group 
versus control group. 
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Table C-2 
Outcome Data Collection 
Tao, G., Xue, Q., Luo, Y., Li, G., Xia, Y., & Yu, B. (2016). Isoflurane is more deleterious to developing brain than desflurane: the role of the Akt/GSK3β 
signaling pathway. BioMed Research International,2016, 1-10. doi:10.1155/2016/7919640 
Data Analysis Results related to apoptosis Results related to behavior and memory 
 
Lithium Pretreatment 
 
Data from western blot 
analyses, fear conditioning test, 
and escape latency/platform 
crossing place trials during the 
water maze trials were 
expressed as means.  
 
MWM used two-way ANOVA 
with Bonferroni correction to 
compare differences in escape 
latency among groups. 
 
T-test and one-way ANOVA 
was used to analyze fear 
conditioning. 
Isoflurane, but not desflurane 
decreased phosphorylation. 
 
Decrement of Akt and GSKB 
phosphorylation has been associated 
with learning and memory 
impairment. 
 
 Isoflurane decreased the expression 
of p-AKT from 100% to 75% with a 
confidence level p < 0.01, whereas 
desflurane results were unchanged 
from the control and remained at 
100%.p > 0.05. 
Expression of GSKB for Isoflurane 
p<0.001 and Desflurane p> 0.05. 
 
 
Isoflurane, but not desflurane impaired 
long-term memory and learning. 
 
Mice in the isoflurane groups  
(p = 0.0001) platform crossing times 
(MWM) were worse than the control 
(oxygen) group (p = 0.0153) and 
desflurane (p = 0.1294). 
 
FCT freezing times showed by one-way 
ANOVA that Isoflurane (p < 0.01) times 
decreased from normal times of 50 second 
to 30 seconds, whereas Desflurane (p > 
0.05) showed minimum change leading to 
believe Isoflurane impaired hippocampus 
memory. 
 
Lithium pretreatment was found to be 
neuroprotective and helped maintain 
learning and memory abilities. 
 
A two-way ANOVA test found that lithium 
administered before isoflurane exposure 
decreased escape latency times in mice 
treated with isoflurane compared to a group 
just receiving saline as a control [F = 
1.741, p = 0.0332] 
 
One-way ANOVA testing demonstrated 
that lithium treatment prior to isoflurane 
exposure reversed isoflurane decreased 
levels of p-Akt of p < 0.05 and p-GSKB 
expression P< 0.01 leading to believe that 
lithium treatment offers some reversal of 
isoflurane neurotoxicity.   
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Table C-3 
Outcome Data Collection 
Wu, C., Wang, J., Guo, X., & Zhang, Y. (2018). Ketamine exacerbates cortical neuroapoptosis under hyperoxic conditions by upregulating expression of the N-
methyl-D-aspartate receptor subunit NR1 in the developing rat brain. BMC Anesthesiology,18(1). doi:10.1186/s12871-018-0511-y 
Data Analysis 
 
Results related to arterial 
oxygenation saturation 
Results related to neural apoptosis Results related to effect on mRNA and 
NR1 
All values expressed as mean +/- 
standard deviation. Differences were 
analyzed by Analysis of Variance 
(ANOVA) by SPSS statistical 
software.  
 
Statistical significance was defined as 
p > 0.05 
 
 
Ketamine alone had no effect on 
paO2. 
 
Rat pups exposed to hyperoxia 
alone had no affect to those of the 
control group (p > 0.05). Control 
group PaO2 89% versus 91.5% for 
the Ketamine alone group. 
 
Ketamine and hyperoxia 
together increased PaO2. 
 
PaO2 was increased to 55% from 
the control group. (p > 0.01).  
 
No changes in pH, SaO2, or PaCO2 
were noted in the four groups. 
 
 
Ketamine with and without 
hyperoxia caused apoptosis in the 
frontal cortex. 
 
Hyperoxia alone: Rat pups 
exposed to hyperoxia alone had 
apoptic scores similar (around 1%) 
to those of the control group (p > 
0.05).  
 
Ketamine without hyperoxia: 
increased amount of apoptic cell 
death (p > 0.01) around 30%. 
 
Ketamine with hyperoxia: 
increased amount of apoptic cell 
death (p > 0.01) around 55%. 
 
 
Ketamine with and  without hyperoxia 
increases the expression of mRNA and 
NR1. NR1 increase is related to increased 
neurotoxicity. 
 
Ketamine without hyperoxia: increased 
amount of mRNA and NR1 subunit 
expression from 0.3 unitsin the control 
group versus 0.7 units in the ketamine 
alone group (p > 0.01). 
 
Ketamine with hyperoxia: increased 
amount of mRNA and NR1 subunit 
expression from  0.3 units in the control 
group versus 1.6 units in the ketamine with 
hyperoxia (p > 0.01). 
 
No affect with the hyperoxia only group 
versus the control (p > 0.05). 
 
 
57 
Appendix C 
Table C-4 
Outcome Data Collection 
Zheng, S. Q., An, L. X., Cheng, X., & Wang, Y. J. (2013). Sevoflurane causes neuronal apoptosis and adaptability changes of  
neonatal rats. Acta Anaesthesiologica Scandinavica,57(9), 1167-1174. doi:10.1111/aas.12163 
 
Data Analysis Results related to Respiratory 
Compensation under Sevoflurane 
exposure 
Results related to apoptosis Results related to behavior and 
memory 
Western Blot Analysis and 
Histopathologic studies, minimal 
group size of 6 determined to detect 
a difference between means of 40% 
with an 80% power significance 
level of 0.05 (p=0.05).  
 
 
Data was expressed as standard 
deviation. Difference comparison 
was determined using Analysis of 
Variance (ANOVA). 
 
 
Neonatal exposure to 2% 
sevoflurane causes no significant 
disturbance of ventilation and 
oxygen. 
 
pH levels remained within normal 
limits for compensated acidosis for 
2% sevoflurane. 
 
pH 7.34 without sevoflurane. 
 
pH 7.37 after 2-hour sevoflurane 
exposure. 
 
pH 7.31 after 4-hour sevoflurane 
exposure. 
 
Exposure to sevoflurane causes a 
time-dependent apoptic 
neurodegeneration (p < 0.05) in 
hippocampus. Higher amounts of 
Capase-3 cells were detected. Rats 
exposed to 2% sevo for 4 hours had 
the most. Control 13 vs Sevo 4 hours 
18 
 
Exposure to sevoflurane induces 
cleavage of PARP-1 in hippocampus 
(p < 0.05) increase then control 
group. 
 
 
Exposure to sevoflurane enhances 
excitability of the rats. 
Rats exposed to sevo had more 
movements than control group  
(p < 0.05) 
 
Exposure to sevoflurane had no 
significant impairment of memory 
and learning in the rats. 
Control group took a 130 cm path to 
the platform during the Morris water 
maze versus 120 cm for Sevoflurane 
exposed 
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ARRIVE Grading Score 
References    Methodology 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Zheng et al. 
(2013)	 RCT 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 
Tao et al. 
(2016) 
RCT 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 
O’ Farrell et 
al. (2018) 
RCT 1 1 1 1 0 1 1 1 0 1 0 1 1 1 1 1 1 1 1 0 
Wu et al. 
(2018) 
RCT 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 
 
 
Methodology Key 
Item 
1. Title         
2. Abstract     
3. Background        
4. Objectives          
5. Ethical Statement     
6. Study Design 
7. Experimental Procedures 
8. Experimental Animals 
9. Housing and Husbandry 
10. Sample Size 
11.  Animal Group Allocation 
12. Experimental Outcomes 
13. Statistical Methods 
14. Baseline Data 
15. Numbers Analyzed 
16. Outcomes and Estimation 
17. Adverse Events 
18. Interpretation/ Scientific Implications 
19. Generalizability/Translation 
20. Funding 
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Cross-study Analysis 
Author/Year/Anesthetic  Behavioral Analysis 
Results 
Histological Study Results Neurodegeneration Results 
O’ Farrell et al. (2018) 
(Volatile Gas) 
-Sevoflurane  and isoflurane 
enhance excitability. 
 
 
-Piriform cortical cells were counted. 
A significant reduction in cells were 
found in isoflurane (p = 0.04) and 
sevoflurane (p = 0.02) exposed 
groups when compared to control 
groups. 
-Sevoflurane was found to induce less neurotoxicity 
than isoflurane. The number of apoptic cells in 
sevoflurane exposed rats at 48 hours post exposure 
were 1.75 micrometer, versus 2.25 micrometers in 
isoflurane rats. At 6 hours post exposure sevofluranre 
rats remained at 1 micrometer versus 2.25 in those 
exposed to isoflurane (p <0.05). 
Tao et al. (2016) 
(Volatile Gas) 
-Isoflurane affected long-
term memory and learning; 
desflurane did not. 
Platform crossing times with 
the Morris Water Maze were 
higher in isoflurane exposed 
rats (80 seconds) versus (60 
seconds) the control and 
desflurane rat groups. 
- There was decreased 
phosphorylation of Akt and GSK3B 
in isoflurane exposed, but not 
desflurane exposed rats. Desflurane 
remained at 100% levels whereas 
isoflurane dropped to approximately 
75% in Akt and GSKB levels.  
-Isoflurane was found to induce more neurotoxicity 
than desflurane. A reduction was found in Akt and 
GSK3B enzyme levels that are used in signaling 
pathways linked to brain development and learning. 
Wu et al. (2018) 
(Ketamine) 
 
N/A 
-Higher mRNA and NR-1 subunit 
expression in those exposed to 
ketamine, ketamine + hyperoxia.  
-Ketamine with, and without, hyperoxia exposure 
increases neuroapoptosis. Apoptic cells of Ketamine 
exposed rats increased 35% versus the control group. 
Ketamine + hyperoxia exposure increased the amount 
of apoptic cells to 55% above the control group. 
Zheng et al. (2013) 
(Volatile Gas) 
-Sevoflurane enhances 
excitability. More 
movements were found in 
flat plane and vertical plane 
with sevoflurane exposure 
(p<0.05). 
-Sevoflurane exposure increases 
cleavage of PARP-1 in the 
hippocampus. 1.2 Beta Lactin versus 
0.7 in the control group (p<0.05). 
- Exposure to sevoflurane in the neonatal rat 
induces apoptic neurodegeneration. 
23 Capase-3 Positive Cells (apoptic cells) versus 17 in 
the control group (p<0.05). 
 
